1
|
Mihret W, Sletbakk Brusletto B, Øvstebø R, Siebke Troseid AM, Norheim G, Merid Y, Kassu A, Abebe W, Ayele S, Silamsaw Asres M, Yamuah L, Aseffa A, Petros B, Caugant DA, Brandtzaeg P. Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia. Innate Immun 2019; 25:158-167. [PMID: 30894090 PMCID: PMC6830936 DOI: 10.1177/1753425918806363] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Revised: 09/16/2018] [Accepted: 09/19/2018] [Indexed: 02/05/2023] Open
Abstract
Neisseria meningitidis infections in sub-Saharan Africa usually present with distinct symptoms of meningitis but very rarely as fulminant septicemia when reaching hospitals. In Europe, development of persistent meningococcal shock and multiple organ failure occurs in up to 30% of patients and is associated with a bacterial load of >106/ml plasma or serum. We have prospectively studied 27 Ethiopian patients with meningococcal infection as diagnosed and quantified with real-time PCR in the cerebrospinal fluid (CSF) and serum. All presented with symptoms of meningitis and none with fulminant septicemia. The median N. meningitidis copy number (NmDNA) in serum was < 3.5 × 103/ml, never exceeded 1.8 × 105/ml, and was always 10-1000 times higher in CSF than in serum. The levels of LPS in CSF as determined by the limulus amebocyte lysate assay were positively correlated to NmDNA copy number ( r = 0.45, P = 0.030), levels of IL-1 receptor antagonist, ( r = 0.46, P = 0.017), and matrix metallopeptidase-9 (MMP-9; r = 0.009). We also compared the inflammatory profiles of 19 mediators in CSF of the 26 meningococcal patients (2 died and 2 had immediate severe sequelae) with 16 patients with Streptococcus pneumoniae meningitis (3 died and 3 with immediate severe sequelae). Of 19 inflammatory mediators tested, 9 were significantly higher in patients with pneumococcal meningitis and possibly linked to worse outcome.
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Child
- Child, Preschool
- Cytokines/genetics
- Cytokines/metabolism
- DNA, Bacterial/blood
- DNA, Bacterial/cerebrospinal fluid
- Epidemics
- Ethiopia/epidemiology
- Female
- Humans
- Infant
- Inflammation Mediators/metabolism
- Male
- Matrix Metalloproteinase 9/genetics
- Matrix Metalloproteinase 9/metabolism
- Meningitis, Meningococcal/epidemiology
- Meningitis, Meningococcal/immunology
- Meningitis, Meningococcal/mortality
- Meningitis, Pneumococcal/epidemiology
- Meningitis, Pneumococcal/immunology
- Meningitis, Pneumococcal/mortality
- Middle Aged
- Neisseria meningitidis/physiology
- Pathology, Molecular
- Prospective Studies
- Sepsis
- Streptococcus pneumoniae/physiology
- Survival Analysis
- Young Adult
Collapse
Affiliation(s)
- Wude Mihret
- Department of Microbial and Cellular Molecular Biology, Addis
Ababa University, Ethiopia
- Armauer Hansen Research Institute, Addis Ababa, Ethiopia
| | | | - Reidun Øvstebø
- Department of Clinical Chemistry, Oslo University Hospital,
Norway
| | | | | | | | | | | | - Samuel Ayele
- Armauer Hansen Research Institute, Addis Ababa, Ethiopia
| | | | | | - Abraham Aseffa
- Armauer Hansen Research Institute, Addis Ababa, Ethiopia
| | | | - Dominique A. Caugant
- Institute of Public Health, Oslo, Norway
- Institute of Public Health and Society, University of Oslo,
Norway
| | - Petter Brandtzaeg
- Department of Clinical Chemistry, Oslo University Hospital,
Norway
- Department of Pediatrics, Oslo University Hospital, Norway
- Institute of Clinical Medicine, Faculty of Medicine, University
of Oslo, Norway
| |
Collapse
|
2
|
Colicchio R, Pagliuca C, Ricci S, Scaglione E, Grandgirard D, Masouris I, Farina F, Pagliarulo C, Mantova G, Paragliola L, Leib SL, Koedel U, Pozzi G, Alifano P, Salvatore P. Virulence Traits of a Serogroup C Meningococcus and Isogenic cssA Mutant, Defective in Surface-Exposed Sialic Acid, in a Murine Model of Meningitis. Infect Immun 2019; 87:e00688-18. [PMID: 30718288 PMCID: PMC6434112 DOI: 10.1128/iai.00688-18] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2018] [Accepted: 01/29/2019] [Indexed: 12/17/2022] Open
Abstract
In serogroup C Neisseria meningitidis, the cssA (siaA) gene codes for an UDP-N-acetylglucosamine 2-epimerase that catalyzes the conversion of UDP-N-acetyl-α-d-glucosamine into N-acetyl-d-mannosamine and UDP in the first step in sialic acid biosynthesis. This enzyme is required for the biosynthesis of the (α2→9)-linked polysialic acid capsule and for lipooligosaccharide (LOS) sialylation. In this study, we have used a reference serogroup C meningococcal strain and an isogenic cssA knockout mutant to investigate the pathogenetic role of surface-exposed sialic acids in a model of meningitis based on intracisternal inoculation of BALB/c mice. Results confirmed the key role of surface-exposed sialic acids in meningococcal pathogenesis. The 50% lethal dose (LD50) of the wild-type strain 93/4286 was about four orders of magnitude lower than that of the cssA mutant. Compared to the wild-type strain, the ability of this mutant to replicate in brain and spread systemically was severely impaired. Evaluation of brain damage evidenced a significant reduction in cerebral hemorrhages in mice infected with the mutant in comparison with the levels in those challenged with the wild-type strain. Histological analysis showed the typical features of bacterial meningitis, including inflammatory cells in the subarachnoid, perivascular, and ventricular spaces especially in animals infected with the wild type. Noticeably, 80% of mice infected with the wild-type strain presented with massive bacterial localization and accompanying inflammatory infiltrate in the corpus callosum, indicating high tropism of meningococci exposing sialic acids toward this brain structure and a specific involvement of the corpus callosum in the mouse model of meningococcal meningitis.
Collapse
Affiliation(s)
- Roberta Colicchio
- Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy
| | - Chiara Pagliuca
- Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy
| | - Susanna Ricci
- Laboratory of Molecular Microbiology and Biotechnology (LAMMB), Department of Medical Biotechnologies, University of Siena, Siena, Italy
| | - Elena Scaglione
- Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy
| | - Denis Grandgirard
- Institute for Infectious Diseases, University of Bern, Bern, Switzerland
| | - Ilias Masouris
- Department of Neurology, Ludwig Maximilians University of Munich, Munich, Germany
| | - Fabrizio Farina
- Department of Law, Economics, Management and Quantitative Methods, University of Sannio, Benevento, Italy
| | | | - Giuseppe Mantova
- Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy
| | - Laura Paragliola
- Department of Integrated Activity of Laboratory Medicine and Transfusion, Complex Operative Unit of Clinical Microbiology, University Hospital Federico II, Naples, Italy
| | - Stephen L Leib
- Institute for Infectious Diseases, University of Bern, Bern, Switzerland
| | - Uwe Koedel
- Department of Neurology, Ludwig Maximilians University of Munich, Munich, Germany
| | - Gianni Pozzi
- Laboratory of Molecular Microbiology and Biotechnology (LAMMB), Department of Medical Biotechnologies, University of Siena, Siena, Italy
| | - Pietro Alifano
- Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy
| | - Paola Salvatore
- Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy
- Department of Integrated Activity of Laboratory Medicine and Transfusion, Complex Operative Unit of Clinical Microbiology, University Hospital Federico II, Naples, Italy
- CEINGE, Biotecnologie Avanzate s.c.ar.l., Naples, Italy
| |
Collapse
|
3
|
Guiducci S, Moriondo M, Nieddu F, Ricci S, De Vitis E, Casini A, Poggi GM, Indolfi G, Resti M, Azzari C. Culture and Real-time Polymerase Chain reaction sensitivity in the diagnosis of invasive meningococcal disease: Does culture miss less severe cases? PLoS One 2019; 14:e0212922. [PMID: 30865671 PMCID: PMC6415896 DOI: 10.1371/journal.pone.0212922] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2018] [Accepted: 02/12/2019] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Invasive meningococcal disease (IMD) is a highly lethal disease. Diagnosis is commonly performed by culture or Realtime-PCR (qPCR). AIMS Our aim was to evaluate, retrospectively, whether culture positivity correlates with higher bacterial load and fatal outcome. Our secondary aim was to compare culture and qPCR sensitivity. METHODS The National Register for Molecular Surveillance was used as data source. Cycle threshold (CT), known to be inversely correlated with bacterial load, was used to compare bacterial load in different samples. RESULTS Three-hundred-thirteen patients were found positive for Neisseria meningitidis by qPCR, or culture, or both; 41 died (case fatality rate 13.1%); 128/143 (89.5%) blood samples and 138/144 (95.8%) CSF were positive by qPCR, 37/143 (25.9%) blood samples and 45/144 (31.2%) CSF were also positive in culture. qPCR was 3.5 times (blood) or 3.1 times (CSF) more sensitive than culture in achieving a laboratory diagnosis of IMD (OR 24.4; 95% CI 12.2-49.8; p < .10-4; Cohen's κ 0.08 for blood and OR 49.0; 95% CI 19.1-133.4; p<10-4; Cohen's κ 0.02; for CSF). Positivity of culture did not correlate with higher bacterial loads in blood (mean CT 27.7±5.71, and CT 28.1±6.03, p = 0.739 respectively in culture positive or negative samples) or in CSF (mean CT 23.1±4.9 and 24.7±5.4 respectively in positive or negative CSF samples, p = 0.11).CT values in blood from patients who died were significantly lower than in patients who survived (respectively mean 18.0, range 14-23 and mean 29.6, range 16-39; p<10-17). No deaths occurred in patients with CT in blood over 23. Positive blood cultures were found in 10/25 (40%) patients who died and in 32/163 (19.6%) patients who survived, p = 0.036, OR 2.73; 95% CL 1.025-7.215), however 60% of deaths would have remained undiagnosed with the use of culture only. CONCLUSIONS In conclusion our study demonstrated that qPCR is significantly (at least 3 times) more sensitive than culture in the laboratory confirmation of IMD. The study also demonstrated that culture negativity is not associated with lower bacterial loads and with less severe cases. On the other side, in patients with sepsis, qPCR can predict fatal outcome since higher bacterial load, evaluated by qPCR, appears strictly associated with most severe cases and fatal outcome. The study also showed that molecular techniques such as qPCR can provide a valuable addition to the proportion of diagnosed and serotyped cases of IMD.
Collapse
Affiliation(s)
- Sara Guiducci
- Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy
- Pediatric Clinic 2, Pediatric Immunology, Meyer Children’s Hospital, Florence, Italy
| | - Maria Moriondo
- Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy
| | - Francesco Nieddu
- Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy
- Pediatric Clinic 2, Pediatric Immunology, Meyer Children’s Hospital, Florence, Italy
- * E-mail:
| | - Silvia Ricci
- Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy
- Pediatric Clinic 2, Pediatric Immunology, Meyer Children’s Hospital, Florence, Italy
| | - Elisa De Vitis
- Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy
- Pediatric Clinic 2, Pediatric Immunology, Meyer Children’s Hospital, Florence, Italy
| | - Arianna Casini
- Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy
| | - Giovanni Maria Poggi
- Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy
- Department of Interdisciplinary Pediatrics, Section of Medical Pediatrics, Meyer Children's Hospital, Florence, Italy
| | - Giuseppe Indolfi
- Department of Interdisciplinary Pediatrics, Section of Medical Pediatrics, Meyer Children's Hospital, Florence, Italy
| | - Massimo Resti
- Department of Interdisciplinary Pediatrics, Section of Medical Pediatrics, Meyer Children's Hospital, Florence, Italy
| | - Chiara Azzari
- Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy
- Pediatric Clinic 2, Pediatric Immunology, Meyer Children’s Hospital, Florence, Italy
| |
Collapse
|
4
|
Hassan A, Mustapha GU, Lawal BB, Na’uzo AM, Ismail R, Womi-Eteng Oboma E, Oyebanji O, Agenyi J, Thomas C, Balogun MS, Dalhat MM, Nguku P, Ihekweazu C. Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017. PLoS One 2018; 13:e0199257. [PMID: 29920549 PMCID: PMC6007901 DOI: 10.1371/journal.pone.0199257] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Accepted: 06/04/2018] [Indexed: 11/18/2022] Open
Abstract
Background Nigeria reports high rates of mortality linked with recurring meningococcal meningitis outbreaks within the African meningitis belt. Few studies have thoroughly described the response to these outbreaks to provide strong and actionable public health messages. We describe how time delays affected the response to the 2016/2017 meningococcal meningitis outbreak in Nigeria. Methods Using data from Nigeria Centre for Disease Control (NCDC), National Primary Health Care Development Agency (NPHCDA), World Health Organisation (WHO), and situation reports of rapid response teams, we calculated attack and death rates of reported suspected meningococcal meningitis cases per week in Zamfara, Sokoto and Yobe states respectively, between epidemiological week 49 in 2016 and epidemiological week 25 in 2017. We identified when alert and epidemic thresholds were crossed and determined when the outbreak was detected and notified in each state. We examined response activities to the outbreak. Results There were 12,535 suspected meningococcal meningitis cases and 877 deaths (CFR: 7.0%) in the three states. It took an average time of three weeks before the outbreaks were detected and notified to NCDC. Four weeks after receiving notification, an integrated response coordinating centre was set up by NCDC and requests for vaccines were sent to International Coordinating Group (ICG) on vaccine provision. While it took ICG one week to approve the requests, it took an average of two weeks for approximately 41% of requested vaccines to arrive. On the average, it took nine weeks from the date the epidemic threshold was crossed to commencement of reactive vaccination in the three states. Conclusion There were delays in detection and notification of the outbreak, in coordinating response activities, in requesting for vaccines and their arrival from ICG, and in initiating reactive vaccination. Reducing these delays in future outbreaks could help decrease the morbidity and mortality linked with meningococcal meningitis outbreaks.
Collapse
Affiliation(s)
- Assad Hassan
- Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria
- Nigeria Centre for Disease Control, Abuja, Nigeria
- * E-mail:
| | - G. U. Mustapha
- Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria
- Nigeria Centre for Disease Control, Abuja, Nigeria
| | - Bola B. Lawal
- Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria
| | - Aliyu M. Na’uzo
- Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria
| | - Raji Ismail
- Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria
| | | | | | | | | | | | - Mahmood M. Dalhat
- Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria
| | - Patrick Nguku
- Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria
| | | |
Collapse
|
5
|
Coldiron ME, Salou H, Sidikou F, Goumbi K, Djibo A, Lechevalier P, Compaoré I, Grais RF. Case-Fatality Rates and Sequelae Resulting from Neisseria meningitidis Serogroup C Epidemic, Niger, 2015. Emerg Infect Dis 2018; 22:1827-9. [PMID: 27649257 PMCID: PMC5038434 DOI: 10.3201/eid2210.160731] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
We describe clinical symptoms, case-fatality rates, and prevalence of sequelae during an outbreak of Neisseria meningitidis serogroup C infection in a rural district of Niger. During home visits, we established that household contacts of reported case-patients were at higher risk for developing meningitis than the general population.
Collapse
|
6
|
Cordeiro SM, Cardoso CW, de Araújo LG, Ribeiro LE, Azevedo J, Silva RDCV, Dos Reis MG, Ko AI, Reis JN. Dissemination of the ST-103 clonal complex serogroup C meningococci in Salvador, Brazil. Microbes Infect 2018; 20:19-24. [PMID: 28962886 DOI: 10.1016/j.micinf.2017.09.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Revised: 09/21/2017] [Accepted: 09/21/2017] [Indexed: 12/01/2022]
Abstract
Invasive meningococcal disease (IMD) is a major public health problem worldwide. An epidemic of serogroup C (NmC) IMD occurred in 2010 in the city of Salvador. In this study, we describe the antigenic and genetic characterization of meningococcal isolates collected from meningitis cases in Salvador from 2001 to 2012. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were performed for the analysis of IMD isolates. A total of 733 cases were identified, and the serogroup was determined for 391 (53.0%) of these. Most cases were caused by NmC (53%) or B (47%). The most prevalent strains were B:4,7:P1.19,15 (32.9%; 129/391) and C:23:P1.14-6 (28.6%; 112/391). Based on PFGE/MLST analysis, 71.3% (77/108 PFGE-tested isolates) clustered as two clones of sequence type ST-3779 and ST-3780, both belonging to the ST-103 clonal complex. ST-3779 has been detected in Salvador since 1996 and together with ST-3780 became predominant after 2005. There was a predominance of C:23:P1.14-6, ST-3779/3780 in Salvador during the period of 2007-2012, establishing a major clonal lineage, which remained in the community for a long time; this has serious implications for public health, particularly in terms of prevention and control strategies of IMD.
Collapse
Affiliation(s)
- Soraia Machado Cordeiro
- Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Brazil Ministry of Health, Rua Waldemar Falcão, 141, Candeal, Salvador 40296-710, Brazil; School of Pharmacy, Federal University of Bahia, Rua Barão do Jeremoabo, n° 147, Ondina, Salvador, 40170-115, Brazil
| | - Cristiane Wanderley Cardoso
- Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Brazil Ministry of Health, Rua Waldemar Falcão, 141, Candeal, Salvador 40296-710, Brazil; Municipal Secretary of Health of Salvador, Rua da Grécia, 3, Comercio, Salvador 40010-010, Brazil
| | - Lorena Galvão de Araújo
- Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Brazil Ministry of Health, Rua Waldemar Falcão, 141, Candeal, Salvador 40296-710, Brazil
| | - Luis Eduardo Ribeiro
- School of Pharmacy, Federal University of Bahia, Rua Barão do Jeremoabo, n° 147, Ondina, Salvador, 40170-115, Brazil
| | - Jailton Azevedo
- Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Brazil Ministry of Health, Rua Waldemar Falcão, 141, Candeal, Salvador 40296-710, Brazil
| | | | - Mitermayer Galvão Dos Reis
- Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Brazil Ministry of Health, Rua Waldemar Falcão, 141, Candeal, Salvador 40296-710, Brazil
| | - Albert Icksang Ko
- Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Brazil Ministry of Health, Rua Waldemar Falcão, 141, Candeal, Salvador 40296-710, Brazil; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, 60 College Street, New Haven, CT 06520-8034, USA
| | - Joice Neves Reis
- Gonçalo Moniz Research Institute, Oswaldo Cruz Foundation, Brazil Ministry of Health, Rua Waldemar Falcão, 141, Candeal, Salvador 40296-710, Brazil; School of Pharmacy, Federal University of Bahia, Rua Barão do Jeremoabo, n° 147, Ondina, Salvador, 40170-115, Brazil.
| |
Collapse
|
7
|
Patel JC, George J, Vuong J, Potts CC, Bozio C, Clark TA, Thomas J, Schier J, Chang A, Waller JL, Diaz MH, Whaley M, Jenkins LT, Fuller S, Williams DE, Redd JT, Arthur RR, Taweh F, Vera Walker Y, Hardy P, Freeman M, Katawera V, Gwesa G, Gbanya MZ, Clement P, Kohar H, Stone M, Fallah M, Nyenswah T, Winchell JM, Wang X, McNamara LA, Dokubo EK, Fox LM. Rapid Laboratory Identification of Neisseria meningitidis Serogroup C as the Cause of an Outbreak - Liberia, 2017. MMWR Morb Mortal Wkly Rep 2017; 66:1144-1147. [PMID: 29073124 PMCID: PMC5689101 DOI: 10.15585/mmwr.mm6642a5] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
8
|
Abstract
BACKGROUND Meningococcal disease can lead to death or disability within hours after onset. Pre-admission antibiotics aim to reduce the risk of serious disease and death by preventing delays in starting therapy before confirmation of the diagnosis. OBJECTIVES To study the effectiveness and safety of pre-admission antibiotics versus no pre-admission antibiotics or placebo, and different pre-admission antibiotic regimens in decreasing mortality, clinical failure, and morbidity in people suspected of meningococcal disease. SEARCH METHODS We searched CENTRAL (6 January 2017), MEDLINE (1966 to 6 January 2017), Embase (1980 to 6 January 2017), Web of Science (1985 to 6 January 2017), LILACS (1982 to 6 January 2017), and prospective trial registries to January 2017. We previously searched CAB Abstracts from 1985 to June 2015, but did not update this search in January 2017. SELECTION CRITERIA Randomised controlled trials (RCTs) or quasi-RCTs comparing antibiotics versus placebo or no intervention, in people with suspected meningococcal infection, or different antibiotics administered before admission to hospital or confirmation of the diagnosis. DATA COLLECTION AND ANALYSIS Two review authors independently assessed trial quality and extracted data from the search results. We calculated the risk ratio (RR) and 95% confidence interval (CI) for dichotomous data. We included only one trial and so did not perform data synthesis. We assessed the overall quality of the evidence using the GRADE approach. MAIN RESULTS We found no RCTs comparing pre-admission antibiotics versus no pre-admission antibiotics or placebo. We included one open-label, non-inferiority RCT with 510 participants, conducted during an epidemic in Niger, evaluating a single dose of intramuscular ceftriaxone versus a single dose of intramuscular long-acting (oily) chloramphenicol. Ceftriaxone was not inferior to chloramphenicol in reducing mortality (RR 1.21, 95% CI 0.57 to 2.56; N = 503; 308 confirmed meningococcal meningitis; 26 deaths; moderate-quality evidence), clinical failures (RR 0.83, 95% CI 0.32 to 2.15; N = 477; 18 clinical failures; moderate-quality evidence), or neurological sequelae (RR 1.29, 95% CI 0.63 to 2.62; N = 477; 29 with sequelae; low-quality evidence). No adverse effects of treatment were reported. Estimated treatment costs were similar. No data were available on disease burden due to sequelae. AUTHORS' CONCLUSIONS We found no reliable evidence to support the use pre-admission antibiotics for suspected cases of non-severe meningococcal disease. Moderate-quality evidence from one RCT indicated that single intramuscular injections of ceftriaxone and long-acting chloramphenicol were equally effective, safe, and economical in reducing serious outcomes. The choice between these antibiotics should be based on affordability, availability, and patterns of antibiotic resistance.Further RCTs comparing different pre-admission antibiotics, accompanied by intensive supportive measures, are ethically justified in people with less severe illness, and are needed to provide reliable evidence in different clinical settings.
Collapse
Affiliation(s)
- Thambu D Sudarsanam
- Christian Medical CollegeMedicine Unit 2 and Clinical Epidemiology UnitIda Scudder RoadVelloreTamil NaduIndia632 004
| | - Priscilla Rupali
- Christian Medical CollegeDepartment of General Medicine Unit ‐1 & Infectious DiseasesVelloreTamil NaduIndia632004
| | - Prathap Tharyan
- Christian Medical CollegeCochrane South Asia, Prof. BV Moses Center for Evidence‐Informed Health Care and Health PolicyCarman Block II FloorCMC Campus, BagayamVelloreTamil NaduIndia632002
| | | | | | | |
Collapse
|
9
|
Jeger V, Hasse B, Hildenbrand F. [Not Available]. Praxis (Bern 1994) 2016; 105:1353-1360. [PMID: 27854166 DOI: 10.1024/1661-8157/a002552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Zusammenfassung. Die akute bakterielle Meningitis ist ein seltenes Krankheitsbild in der hausärztlichen Praxis mit jedoch hoher Mortalität. Deshalb ist die rasche Diagnose, unmittelbare Hospitalisierung und Einleitung einer empirischen Antibiotikatherapie eine grosse Herausforderung. Die klassische klinische Trias bestehend aus Fieber, Meningismus und Bewusstseinsveränderung ist unspezifisch, und oft sind erste Symptome bei einer Grippe oder einem gastrointestinalen Infekt sehr ähnlich. Bereits bei geringem Verdacht sollte eine Liquorpunktion erfolgen, wobei diese die erste Gabe von Ceftriaxon i.v. nicht verzögern darf. In der empirischen Therapie müssen Meningokokken, Pneumokokken und je nach Risikoprofil auch Listerien sowie mögliche resistente Keime abgedeckt werden.
Collapse
MESH Headings
- Acute Disease
- Adult
- Anti-Bacterial Agents/therapeutic use
- Cerebrospinal Fluid Pressure
- Delayed Diagnosis
- Diagnosis, Differential
- Early Medical Intervention
- Humans
- Male
- Meningitis, Bacterial/diagnosis
- Meningitis, Bacterial/drug therapy
- Meningitis, Bacterial/mortality
- Meningitis, Haemophilus/diagnosis
- Meningitis, Haemophilus/drug therapy
- Meningitis, Haemophilus/mortality
- Meningitis, Meningococcal/diagnosis
- Meningitis, Meningococcal/drug therapy
- Meningitis, Meningococcal/mortality
- Meningitis, Pneumococcal/diagnosis
- Meningitis, Pneumococcal/drug therapy
- Meningitis, Pneumococcal/mortality
- Neurologic Examination
- Spinal Puncture
- Survival Rate
- Young Adult
Collapse
Affiliation(s)
| | - Barbara Hasse
- 2 Klinik für Infektionskrankheiten und Spitalhygiene
| | | |
Collapse
|
10
|
Paul R, Greaves K, Paul SP. Be vigilant at all times. Emerg Nurse 2016; 24:15. [PMID: 27165387 DOI: 10.7748/en.24.2.15.s17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- Ruby Paul
- Peninsula College of Medicine and Dentistry, Plymouth University
| | | | | |
Collapse
|
11
|
Bassey BE, Vaz RG, Gasasira AN, Braka F, Weldegriebriel G, Komakech W, Toritseju MS, Fatiregun AA, Okocha-Ejeko A. Pattern of the meningococcal meningitis outbreak in Northern Nigeria, 2009. Int J Infect Dis 2015; 43:62-67. [PMID: 26724773 DOI: 10.1016/j.ijid.2015.12.016] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2015] [Revised: 12/20/2015] [Accepted: 12/21/2015] [Indexed: 11/17/2022] Open
Abstract
OBJECTIVES Despite the availability of vaccines, children are the people most often affected by epidemic meningococcal meningitis. The pattern of the epidemic meningococcal meningitis outbreak in Northern Nigeria in 2009 and the Neisseria meningitidis strains responsible for this epidemic are described here. METHODS A retrospective cross-sectional study was conducted in 16 states, involving 48 local government areas (LGAs), 91 health facilities, and 96 communities. Data collection involved in-depth interviews with key informants from the federal to the community level, a review of records, and a solution-oriented national workshop with participants from all states of the Federation. Cerebrospinal fluid (CSF) samples were collected from some of the suspected cases at the start of the outbreak and were tested using the rapid Pastorex latex agglutination kit. RESULTS Kastina (11153, 20.4%), Jigawa (8643, 15.8%), Bauchi (8463, 15.5%), Kano (6811, 12.4%), and Gombe (6110, 11.2%) were the states with the highest prevalence of meningitis. The states of Nasarawa (11.0%), Adamawa (8.0%), and Borno (7.6%) recorded the highest percentage of deaths, while the Shongom (Gombe State 12.5%), Illela (Sokoto State 9.8%), and Ikara (Kaduna State 9.1%) LGAs recorded the most deaths amongst cases seen. CONCLUSIONS The testing of CSF samples during meningitis outbreaks is recommended in order to monitor the occurrence of the multiple meningitis serotypes during these outbreaks and to direct serotype-specific vaccination response activities.
Collapse
Affiliation(s)
- Bassey Enya Bassey
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
| | - Rui Gama Vaz
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria
| | - Alex Ntale Gasasira
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria
| | - Fiona Braka
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria
| | - Goitom Weldegriebriel
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria
| | - Williams Komakech
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria
| | - Maleghemi Sylvester Toritseju
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria
| | - Akinola Ayoola Fatiregun
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria
| | - Angela Okocha-Ejeko
- World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria
| |
Collapse
|
12
|
Stetefeld HR, Dohmen C. [Acute care of patients with bacterial meningitis]. Med Klin Intensivmed Notfmed 2015; 111:215-23. [PMID: 25876743 DOI: 10.1007/s00063-015-0021-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2014] [Revised: 02/17/2015] [Accepted: 02/27/2015] [Indexed: 11/26/2022]
Abstract
BACKGROUND Bacterial meningitis is a life-threatening emergency that is still associated with high mortality and poor outcome. OBJECTIVE The purpose of this article is to provide a review of clinical presentation, diagnostic procedure, therapy, and prognosis in bacterial meningitis. Prognostic factors which could be influenced positively are identified and a focused procedure in the emergency setting and for the treatment of complications are provided. MATERIAL AND METHODS This work is based on a literature search (PubMed, guidelines) and personal experience (standard operating procedures, SOP). RESULTS Despite improved health care, bacterial meningitis is still associated with high mortality and poor neurological outcome, which has remained largely unaltered during recent decades. Diagnosis and, more importantly, effective therapy of bacterial meningitis are often delayed, having an immediate negative influence on clinical outcome. Neurological and nonneurological complications often necessitate intensive care and may occur rapidly or in the further course of the disease. CONCLUSION Immediate initiation of effective therapy is crucial to positively influence mortality and neurological outcome. Antibiotics should be administered within 30 min after admission. To achieve this, a focused and well-organized procedure in the emergency setting is necessary. Because of intra- and extracranial complications, patients need to be treated on intensive care units including neurological expertise and interdisciplinary support.
Collapse
Affiliation(s)
- H R Stetefeld
- Abteilung für Neurologie, Universitätsklinikum Köln, Kerpener Str. 62, 50924, Köln, Deutschland.
| | - C Dohmen
- Abteilung für Neurologie, Universitätsklinikum Köln, Kerpener Str. 62, 50924, Köln, Deutschland
| |
Collapse
|
13
|
Skoczyńska A, Waśko I, Kuch A, Kadłubowski M, Gołębiewska A, Foryś M, Markowska M, Ronkiewicz P, Wasiak K, Kozińska A, Matynia B, Hryniewicz W. A decade of invasive meningococcal disease surveillance in Poland. PLoS One 2013; 8:e71943. [PMID: 23977184 PMCID: PMC3748050 DOI: 10.1371/journal.pone.0071943] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2013] [Accepted: 07/04/2013] [Indexed: 11/21/2022] Open
Abstract
Background Neisseria meningitidis is a leading etiologic agent of severe invasive disease. The objective of the study was to characterise invasive meningococcal disease (IMD) epidemiology in Poland during the last decade, based on laboratory confirmed cases. Methods The study encompassed all invasive meningococci collected between 2002 and 2011 in the National Reference Centre for Bacterial Meningitis. The isolates were re-identified and characterised by susceptibility testing, MLST analysis, porA and fetA sequencing. A PCR technique was used for meningococcal identification directly from clinical materials. Results In the period studied, 1936 cases of IMD were confirmed, including 75.6% identified by culture. Seven IMD outbreaks, affecting mostly adolescents, were reported; all were caused by serogroup C meningococci of ST-11. The highest incidence was observed among children under one year of age (15.71/100,000 in 2011). The general case fatality rate in the years 2010–2011 was 10.0%. Meningococci of serogroup B, C, Y and W-135 were responsible for 48.8%, 36.6%, 1.2% and 1.2% of cases, respectively. All isolates were susceptible to third generation cephalosporins, chloramphenicol, ciprofloxacin, and 84.2% were susceptible to penicillin. MLST analysis (2009–2011) revealed that among serogroup B isolates the most represented were clonal complexes (CC) ST-32CC, ST-18CC, ST-41/44CC, ST-213CC and ST-269CC, and among serogroup C: ST-103CC, ST-41/44CC and ST-11CC. Conclusions The detection of IMD in Poland has changed over time, but observed increase in the incidence of the disease was mostly attributed to changes in the surveillance system including an expanded case definition and inclusion of data from non-culture diagnostics.
Collapse
Affiliation(s)
- Anna Skoczyńska
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
- * E-mail:
| | - Izabela Waśko
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Alicja Kuch
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Marcin Kadłubowski
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Agnieszka Gołębiewska
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Małgorzata Foryś
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Marlena Markowska
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Patrycja Ronkiewicz
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Katarzyna Wasiak
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Aleksandra Kozińska
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Bożena Matynia
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | - Waleria Hryniewicz
- National Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
| | | |
Collapse
|
14
|
Xu XH, Ye Y, Hu LF, Jin YH, Jiang QQ, Li JB. Emergence of serogroup C meningococcal disease associated with a high mortality rate in Hefei, China. BMC Infect Dis 2012; 12:205. [PMID: 22943188 PMCID: PMC3459715 DOI: 10.1186/1471-2334-12-205] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2011] [Accepted: 08/23/2012] [Indexed: 12/05/2022] Open
Abstract
BACKGROUND Neisseria meningitidis serogroup C has emerged as a cause of epidemic disease in Hefei. The establishment of serogroup C as the predominant cause of endemic disease has not been described. METHODS We conducted national laboratory-based surveillance for invasive meningococcal disease during 2000-2010. Isolates were characterized by pulsed-field gel electrophoresis and multilocus sequence typing. RESULTS A total of 845 cases of invasive meningococcal disease were reported. The incidence increased from 1.25 cases per 100,000 population in 2000 to 3.14 cases per 100,000 in 2003 (p < 0.001), and peaked at 8.43 cases per 100,000 in 2005. The increase was mainly the result of an increase in the incidence of serogroup C disease. Serogroup C disease increased from 2/23 (9%) meningococcal cases and 0.11 cases per 100,000 in 2000 to 33/58 (57%) cases and 1.76 cases per 100,000 in 2003 (p < 0.01). Patients infected with serogroup C had serious complications more frequently than those infected with other serogroups. Specifically, 161/493 (32.7%) cases infected with serogroup C had at least one complication. The case-fatality rate of serogroup C meningitis was 11.4%, significantly higher than for serogroup A meningitis (5.3%, p = 0.021). Among patients with meningococcal disease, factors associated with death in univariate analysis were age of 15-24 years, infection with serogroup C, and meningococcemia. CONCLUSIONS The incidence of meningococcal disease has substantially increased and serogroup C has become endemic in Hefei. The serogroup C strain has caused more severe disease than the previously predominant serogroup A strain.
Collapse
Affiliation(s)
- Xi-Hai Xu
- Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Ying Ye
- Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Li-Fen Hu
- Anhui Center for Surveillance of Bacterial Resistance, Hefei, Anhui, China
- Department of Center Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Yu-Hui Jin
- Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China
| | - Qin-Qin Jiang
- Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China
| | - Jia-Bin Li
- Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
- Anhui Center for Surveillance of Bacterial Resistance, Hefei, Anhui, China
| |
Collapse
|
15
|
Nau JY. [Africa: towards the eradication of meningitis A?]. Rev Med Suisse 2011; 7:1378-1379. [PMID: 21815540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
|
16
|
Hedberg ST, Törös B, Fredlund H, Olcén P, Mölling P. Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. Euro Surveill 2011; 16:19885. [PMID: 21679677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
Neisseria meningitidis serogroups B and C have been responsible for the majority of invasive meningococcal disease in Europe. Recently, an increase of N. meningitidis disease due to serogroup Y has been noted in Sweden (in 2010, the proportion was 39%, with an incidence of 0.23 per 100,000 population), as well as in other northern European countries. We aimed to investigate the clonal pattern of the emerging serogroup Y in Sweden during 2000 to 2010. The serogroup Y isolates identified during this time (n=85) were characterised by multilocus sequence typing and sequencing of the fetA, fHbp, penA, porA and porB genes. The most frequent clone (comprising 28 isolates) with identical allele combinations of the investigated genes, was partly responsible for the observed increased number of N. meningitidis serogroup Y isolates. It was sulfadiazine resistant, with genosubtype P1.5-2,10-1,36-2, sequence type 23, clonal complex 23, porB allele 3-36, fetA allele F4-1, fHbp allele 25 and penA allele 22. The first case with disease due to this clone was identified in 2002: there was a further case in 2004, six during 2006 to 2007, eight during 2008 to 2009, with a peak of 12 cases in 2010. An unusual increase of invasive disease in young adults (aged 20–29 years) caused by this clone was shown, but no increase in mortality rate was observed.
Collapse
Affiliation(s)
- S Thulin Hedberg
- National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Clinical Microbiology, orebro University Hospital, orebro, Sweden
| | | | | | | | | |
Collapse
|
17
|
Rajapaksa S, Starr M. Meningococcal sepsis. Aust Fam Physician 2010; 39:276-278. [PMID: 20485712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
BACKGROUND Meningococcal disease remains a significant illness with an overall mortality of around 8%. The majority of deaths occur in the first 24 hours, before the commencement of specialist care. Missing a diagnosis of meningococcal disease is a fear among health care practitioners. OBJECTIVE This article presents a guide to identifying the salient features of meningococcal sepsis and initial management strategies in the primary care setting. DISCUSSION Initial presentation is often nonspecific and therefore it is important to have a high index of suspicion in children presenting with fever, lethargy, myalgia, vomiting and headache. These children should be monitored and reviewed carefully. If a nonblanching rash develops, immediate treatment, liaison with a paediatric intensive care unit and urgent hospital transfer is required. Initial management involves assessment and regular review of airway, breathing and circulation. Antibiotics (preferably intravenous cephalosporin) should be administered before hospital transfer.
Collapse
Affiliation(s)
- Shabna Rajapaksa
- Emergency Department, Royal Children's Hospital, Melbourne, Victoria, Australia.
| | | |
Collapse
|
18
|
Kiliç A, Jolley KA, Beşirbellioğlu B, Koçak N, Bedir O, Eyigün CP, Başustaoğlu AC. [Genotypic characteristics of Neisseria meningitidis serogroup W-135 strains isolated as the agent of fatal meningitis in a military hospital]. MIKROBIYOL BUL 2009; 43:515-517. [PMID: 19795630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The aim of this study was to describe the genetic characterization of a total of 6 Neisseria meningitidis serogroup W-135 strains isolated from patients with meningitis and carriers in a military hospital in 2007-2008. Suspected colonies on modified Thayer-Martin medium plates were screened for oxidase reactivity and Gram stain. If gram-negative diplococci were present, a biochemical profile by the API NH system was used for species confirmation. Pulse field gel electrophoresis typing of Nhel-digested DNA was performed by a previously described method. Multi-locus sequence typing (MLST) was performed using the standard primers as listed on the Neisseria MLST website. Three distinct sequence types (STs) were identified: ST-11, ST-2754, ST-3751. One of the clinical isolates was identified as the same sequence type with Hajj isolate (ST-11) and the isolate with ST-2754 was the same as the first Turkish clinical strain isolated in 2003. These data demonstrated that along with ST-11 which is a known Hajj isolate, the ST-2754 strain causing meningococcal disease in Turkey beginning from the year 2003, should be carefully monitored.
Collapse
|
19
|
Cheng H, Wang DH, Tan CS. [Epidemiological characteristic analysis of the meningococcal meningitis in Jiangxi province during 2004-2007]. Zhongguo Yi Miao He Mian Yi 2009; 15:236-237. [PMID: 20084890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
OBJECTIVE To analyze the epidemiological characteristics of meningococcal meningitis in Jiangxi province, and provide basis for the disease control and prevention. METHODS Adopted description epidemiological method to analyze epidemic situation of meningococcal meningitis. Data collected from Jiangxi disease surveillance information system. RESULTS The incidence of meningococcal meningitis was 0.069-0.129/100,000, average incidente was 0.105/100,000 and the death rate was 2.2%-16.7%. The seasons peak of incidence meningococcal meningitis was 1-4 month. The cases of children who younger than 15-years-old accounted for 75.4% of the total cases. The cases of students was 57.5% of total cases. C group of meningococcal meningitis was 73.9% of total inspected meningococcal meningitis. CONCLUSIONS Meningococcal meningitis vaccination should be integrated into Expanded Program on Immunization. Practice of immunigation should be standarded. The Surveillance, control and prevention of meningococcal meningitis disease in schools should be strengthened.
Collapse
Affiliation(s)
- Hui Cheng
- Jiangxi Provincial Center for Disease Control and Prevention, Nanchang 330029, Jiangxi, China
| | | | | |
Collapse
|
20
|
Mutonga DM, Pimentel G, Muindi J, Nzioka C, Mutiso J, Klena JD, Morcos M, Ogaro T, Materu S, Tetteh C, Messonnier NE, Breiman RF, Feikin DR. Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006. Am J Trop Med Hyg 2009; 80:619-624. [PMID: 19346388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023] Open
Abstract
The epidemiology of serogroup X meningococcal meningitis in Africa is unknown. During a serogroup X meningococcus outbreak in Kenya, case finding involved record review at health facilities and interviews with health workers and community leaders in West Pokot district. An age- and location-matched case-control study for risk factors was done. From December 2005 to April 2006, 82 suspect cases of meningitis were reported; the epidemic threshold was surpassed within two administrative divisions. Most (58%) cases were 5-24 years old; the case-fatality ratio was 21%. Serogroup X meningococcus was the most common serogroup - 5 (63%) of eight isolates serogrouped. Living in the same compound as another case, preceding upper respiratory tract infection and cooking outside the house were significant risk factors for disease. Serogroup X meningococcus caused an outbreak with similar epidemiology and risk factors as other serogroups. Serogroup-specific laboratory-based surveillance for meningococcus in Africa to detect serogroup X disease should be enhanced.
Collapse
Affiliation(s)
- David M Mutonga
- Centers for Disease Control and Prevention and Kenya Ministry of Public Health and Sanitation, Nairobi, Kenya
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Lin M, Dong BQ, Yang JY. [Epidemiological characteristics of meningococcal meningitis in Guangxi Zhuang Autonomous Region during 1996 and 2007]. Zhongguo Yi Miao He Mian Yi 2009; 15:58-60. [PMID: 20077678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
OBJECTIVE To analyze the epidemiological characteristics of meningococcal meningitis and provide evidences for disease control. METHOD The method of descriptive epidemiology has been used to analyze the data collected. RESULTS A total of 419 cases were reported with meningococcal meningitis between 1996-2007, annual incidence rate was 0.07/100,000. 68 cases were dead and mortatity was 16.23% . Highly sporadic distribution by areas was observed in the cases reported. And the incidence peak was between January and April. The aged was mainly at 0-9 years There was trace that the incidence move to aged at 10 19 years old in recent years. The in-cidence rate was higher in male than that in female. And it was mainly attacked in peasants, students and children left-behined at home. Outbreaks had occasionally occurred in Guangxi. The first outbreak caused by Neisseria meningitidis group C in China was reported. The strains isola-ted mainly were with Neisseria meningitidis group A, which accounting for 61.53% of the strains,followed by group C(15. 38%)and Group B (7.69%). Group A was found to be 100% re-sistant to SMZ-TMP,and both group C and B were 100% resistant to sulfanilamide. 1.28% the prevalence of carrier was confirmed by the throat swabs. The positive rate of titer to group A and C were 29. 95o and 21. 720 respectively, and the mean titers were 4.57 microg/ml and 1.70 microg/ml re-spectively. CONCLUSIONS The characteristics of Meningococcal meningitis are summarized as low incidence,high mortabity,highly sporadic distribution, grouping diversity and increasing incidence in older population. Comprehensive measures with the priority of vaccination is the key measure for meningococcal meningitis control.
Collapse
Affiliation(s)
- Mei Lin
- Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning 530028, Guangxi, China
| | | | | |
Collapse
|
22
|
Vestergård D, David KP. [Global spread of meningococcal serogroup W135]. Ugeskr Laeger 2008; 170:3044-3047. [PMID: 18822228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Worldwide, meningococcal meningitis and sepsis cause 500,000 cases of illness and 50,000 deaths annually. The increase in global travel activity has resulted in a change in the epidemiology of infectious diseases, and an accumulation of evidence now indicates a connection between pilgrimage and the spread of meningococcal serogroup W135. During the past decade a number of cases of meningococcal disease caused by serogroup W135 have been observed in West Africa. The epidemiology of meningococcal disease in the meningitis belt has changed and this calls for awareness when counselling travellers.
Collapse
|
23
|
Muli JM, Seckova S, Sladeckova V, Adamcova J, Rabarova L, Takacova M, Polonova J, Dudasova T, Pauerova K, Namulanda V, Okoth V, Juma O, Diana E, Johnson MJ, Deadline J, Bartkovjak M, Kolenova A, Taziarova M, Benca J, Njambi Z. Meningococcal meningitis is still the commonest neuroinfection in the community in tropics: overview of 62 cases. Neuro Endocrinol Lett 2007; 28 Suppl 3:23-24. [PMID: 18030271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 07/17/2007] [Accepted: 08/12/2007] [Indexed: 05/25/2023]
Abstract
Within last 17 years we went through all charts of bacterial meningitis within our nationwide survey and among 372 cases we found 62 cases of MM, in 12 cases with meningococcal disease (with shock, petechial effusions or disseminated intravascular coagulation or digital gangrenes). MM was usually observed in young adults without any of investigated risk factors like neoplasia, ENT (ear, nose, throat) focuses, elderly age, sepsis, diabetes, alcoholism, trauma, neonatal VLBW etc. Trauma, diabetes mellitus, alcohol abuse and chronic sinusitis/otitis were significantly less frequently found as a risk factor for MM. Mortality was very low, only 4.8% and was lower than overall mortality in CBM (12.4%, NS). Also the proportion of neurologic sequellae (9.7%) and initial treatment failure (8.1%) were comparable or even lower. This positive outcome results are probably because all N. meningitis strains were susceptible to penicillin, chloramphenicol, cefotaxim, cotrimoxazol or ciprofloxacin. Other reason for low mortality was that most cases received oral antibiotic immediately, even before admission (50 of 62). 95.2% of cases survived, 90.3% without any transient neurological residual symptoms.
Collapse
Affiliation(s)
- J M Muli
- St. Elizabeth University College Projects in southern Sudan, Ethiopia, Uganda, Burundi and, Kenya
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
Neisseria meningitidis is an important cause of childhood meningitis and septicaemia. Between 1999 and 2005, 133 invasive meningococcal disease (IMD) cases occurred in Jerusalem, 112 (84.2%) of them in children aged 0-14 years. The annual incidence rate in Jerusalem was higher than the national average (2.45+/-0.6 vs. 1.13+/-0.16/100 000 population, P=0.002). Most of the children (82.1%) were from low socio-economic Arab and Jewish ultra-orthodox communities; mortality was higher among Arab than Jewish children (1.3 vs. 0.22/100 000 person-years, P=0.004). A cluster of 10 children with severe meningococcal sepsis (three fatalities) emerged in the winter of 2003-2004. Compared to the other 102 cases in 1999-2005 both meningococcaemia (100% vs. 51%, P=0.003) and mortality (30% vs. 6.9%, P=0.014) rates were higher. Serogroup B comprised 77.6% of the bacterial isolates. Pulsed-field gel electrophoresis showed considerable variability among cluster isolates, but significant resemblance in Arab cases throughout 1999-2005. The increased susceptibility of specific sub-populations to IMD necessitates further evaluation.
Collapse
Affiliation(s)
- C Stein-Zamir
- Jerusalem District Health Office, Ministry of Health, Israel.
| | | | | | | | | | | |
Collapse
|
25
|
Slinko VG, Sweeny A. Reduction in invasive meningococcal disease in Queensland: a success for immunisation. Commun Dis Intell Q Rep 2007; 31:227-32. [PMID: 17725000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
Since 2003, the Australian government has funded a conjugate serogroup C meningococcal vaccine for those aged over 1 year and born since 1 January 1984. This summary of the epidemiology of invasive meningococcal disease (IMD) in Queensland assesses the effect that the vaccination program has had on IMD notifications. In Queensland, IMD cases are notified to the Notifiable Conditions System by clinicians and laboratories. Additional surveillance data are collected by population health units from relatives of the case, the case and medical practitioners. In 2005, Queensland recorded its lowest number of cases and lowest incidence of IMD since statewide surveillance began. This remained low in 2006. The serogroup C rate in Queensland also declined to its lowest in 2006. The pattern of age specific incidence remains similar, though rates are lower in all but those aged less than 12 months. However, Indigenous rates are still twice non-Indigenous rates. The case fatality rate for IMD (all serogroups) has declined, possibly due to the reduced incidence of serogroup C and septicaemia cases. The program appears to have mostly achieved its aims of: reducing illness and death in the population at highest risk; inducing immunity in those who are vaccinated; and reducing the incidence of disease. However, there is considerable natural fluctuation in the rates of IMD and continued surveillance will be needed to monitor trends.
Collapse
Affiliation(s)
- Vicki G Slinko
- National Centre for Epidemiology and Population Health, Australian National University, Acton, Australian Capital Territory.
| | | |
Collapse
|
26
|
Boisier P, Maïnassara HB, Sidikou F, Djibo S, Kairo KK, Chanteau S. Case-fatality ratio of bacterial meningitis in the African meningitis belt: we can do better. Vaccine 2007; 25 Suppl 1:A24-9. [PMID: 17521784 DOI: 10.1016/j.vaccine.2007.04.036] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
In the African meningitis belt, reported case-fatality ratio (CFR) for meningitis are usually calculated on the basis of presumed cases. We reviewed 3509 presumed cases of bacterial meningitis reported in Niger for which a cerebrospinal fluid (CSF) sample had been tested later at the reference laboratory. The main aetiologies were Neisseria meningitidis (1496 cases), Streptococcus pneumoniae (303 cases) and Haemophilus influenzae (105 cases). The CFR of meningococcal meningitis was lower for serogroup A (5.5%) than for serogroups X (12%) and W135 (12.7%). With a CFR of 49.8%, pneumococcal meningitis, albeit representing only 20.7% of confirmed cases, accounted for 50% of the deaths. The disease burden of pneumococcal meningitis must be better taken into consideration in the future. As most treatments are presumptive, there is a urgent need for an easy-to-administer, cheap first-line treatment effective on N. meningitidis as well as on S. pneumoniae and H. influenzae that would replace the single-dose oily chloramphenicol treatment which is the most frequent treatment administered today, independent of microbial aetiology and season. The development of diagnostic tools really suitable for remote health facilities also is an urgent challenge.
Collapse
MESH Headings
- Adolescent
- Amoxicillin/therapeutic use
- Ampicillin/therapeutic use
- Anti-Bacterial Agents/therapeutic use
- Ceftriaxone/therapeutic use
- Child
- Child, Preschool
- Chloramphenicol/therapeutic use
- Haemophilus influenzae/isolation & purification
- Humans
- Infant
- Infant, Newborn
- Meningitis, Bacterial/cerebrospinal fluid
- Meningitis, Bacterial/drug therapy
- Meningitis, Bacterial/mortality
- Meningitis, Haemophilus/cerebrospinal fluid
- Meningitis, Haemophilus/drug therapy
- Meningitis, Haemophilus/mortality
- Meningitis, Meningococcal/cerebrospinal fluid
- Meningitis, Meningococcal/drug therapy
- Meningitis, Meningococcal/mortality
- Meningitis, Pneumococcal/cerebrospinal fluid
- Meningitis, Pneumococcal/drug therapy
- Meningitis, Pneumococcal/mortality
- Neisseria meningitidis/isolation & purification
- Niger/epidemiology
- Streptococcus pneumoniae/isolation & purification
- Survival Rate
Collapse
Affiliation(s)
- Pascal Boisier
- Centre de Recherche Médicale et Sanitaire (CERMES), BP 10887, Niamey, Niger.
| | | | | | | | | | | |
Collapse
|
27
|
Chippaux JP, Diallo A, Marra A, Etard JF. Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal. Vaccine 2007; 25:1712-8. [PMID: 17240492 DOI: 10.1016/j.vaccine.2006.11.021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2006] [Revised: 11/09/2006] [Accepted: 11/13/2006] [Indexed: 11/21/2022]
Abstract
The occurrence of an outbreak of meningitis during three consecutive years in a study area under demographic and epidemiologic longitudinal surveillance allowed evaluating the impact of mass immunisation campaigns on the incidence of meningitis. During an outbreak of meningitis in the neighbouring region occurred 2 years before the first epidemic wave in the study area, 8 out of the 30 villages of the zone were immunised. The incidences of meningitis in these villages were compared with those of the villages that did not benefited from mass campaign. It appeared a very significant difference between the two groups of villages. More than a half of the cases of meningitis seemed to be avoided in the vaccinated villages compared to the others, suggesting that a previous immunisation limits the diffusion of the epidemic. After the second outbreak hit the study zone, a mass immunisation campaign concerned all the 30 villages. The incidences of meningitis were significantly different between villages according to the observed vaccine coverage. These results indicate that preventive immunisation could have a significant impact on meningitis outbreak diffusion.
Collapse
Affiliation(s)
- J-P Chippaux
- Institut de recherche pour le développement (IRD), UR 010 (Santé de la mère et de l'enfant en milieu tropical: épidémiologie et génétique périnatale), La Paz, Bolivia.
| | | | | | | |
Collapse
|
28
|
Fessler B. ["Typical" symptoms are frequently absent. Every 10th meningococcal C infection is fatal]. MMW Fortschr Med 2006; 148:19. [PMID: 17619339 DOI: 10.1007/bf03364892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
|
29
|
Abstract
The outcome of dosing with beta-lactam antibiotics at 8-h intervals for adult patients with community-acquired acute bacterial meningitis was retrospectively analysed at Sahlgrenska University Hospital, Gothenburg, Sweden. 80 medical records were identified for a 6-y period from 1999 to 2004. The most common pathogens noted were Streptococcus pneumoniae (47.5%), Neiseria meningitidis (12.5%), and Listeria monocytogenes (5.0%). Other bacteria were diagnosed in 16.3% of all episodes, but the bacteriological aetiology remained unknown in 18.8%. 79 episodes of bacterial meningitis were treated with beta-lactam antibiotics at 8-h dosing intervals. The mortality rate in these patients was 6.3%, with an incidence of permanent neurological deficiencies of 24.1%. Our study shows that a low mortality rate can be achieved using beta-lactam antibiotics at longer dosing intervals than usually recommended by international guidelines.
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents/administration & dosage
- Anti-Bacterial Agents/therapeutic use
- Community-Acquired Infections/complications
- Community-Acquired Infections/drug therapy
- Community-Acquired Infections/mortality
- Drug Administration Schedule
- Female
- Humans
- Male
- Meningitis, Bacterial/complications
- Meningitis, Bacterial/drug therapy
- Meningitis, Bacterial/mortality
- Meningitis, Listeria/complications
- Meningitis, Listeria/drug therapy
- Meningitis, Listeria/mortality
- Meningitis, Meningococcal/complications
- Meningitis, Meningococcal/drug therapy
- Meningitis, Meningococcal/mortality
- Meningitis, Pneumococcal/complications
- Meningitis, Pneumococcal/drug therapy
- Meningitis, Pneumococcal/mortality
- Middle Aged
- Retrospective Studies
- Treatment Outcome
- beta-Lactams/administration & dosage
- beta-Lactams/therapeutic use
Collapse
Affiliation(s)
- Magnus Brink
- Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.
| | | |
Collapse
|
30
|
Al Khorasani A, Banajeh S. Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: A 2-year hospital-based study. J Infect 2006; 53:228-34. [PMID: 16434101 DOI: 10.1016/j.jinf.2005.12.004] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2004] [Revised: 12/06/2005] [Accepted: 12/08/2005] [Indexed: 10/25/2022]
Abstract
BACKGROUND Childhood acute bacterial meningitis (ABM) is an important cause of death and long-term neurological disability in Yemen, the only low income-high mortality country in the Arabian Peninsula. The objective of this study was to document the microbial characteristics, the antibacterial sensitivity pattern, and the outcome for children hospitalized with ABM, prior to the introduction of Haemophilus influenzae type b (Hib) vaccine in Yemen. PATIENTS AND METHODS The study was retrospective, conducted at a rural district hospital, serving the rural population of the northern parts of Yemen. All patients aged 1 month-15 years admitted between May 1999 and June 2001, with clinical evidence of meningitis and cerebrospinal fluid (CSF) cultured, were included in the study. Clinical information from case notes, including CSF result and the outcome on discharge, were obtained. Analysis of extracted data was performed using Epi Info software. RESULTS During the 2-year study period, 160 study patients met the inclusion criteria, and 7 (4.4%) were negative for bacterial growth. In the 153 positive cultures there were 46 (30.1%) Streptococcus pneumoniae (SP), 23 (15%) H. influenzae (HI), 81 (52.9) Neisseria meningitidis (NM), 2 (1.3%) Staphylococcus aureus (S. aureus), and 1 (0.7%) Escherichia coli. Sixteen study patients died (overall case fatality rate (CFR) 10%), 7 aged under 12 months, 6 aged 12-60 months, and 3 more than 60 months. Ten deaths were due to SP meningitis, 2 HI meningitis, 3 NM meningitis, and 1 had S. aureus. Of the 144 survivors, 28 (19.4%) developed permanent neurological complications, 17 aged less than 12 months, 6 aged 12-60 months, and 5 more than 60 months. SP meningitis accounted for 57.1% (16/28), and 6 (21.4%) had HI meningitis. Among the 89 aged 1-60 months, 13 died (CFR 14.6%), and 23 (30.3%) of the 76 survivors developed permanent complications. Of those tested 20% and 35% of the 20 HI tested isolates and 9.5% and 14.3% of the 42 SP isolates, were resistant to ampicillin and penicillin G, respectively, and the majority of the 81 NM isolates were sensitive to both. The 3 pathogens were largely resistant to gentamicin, and almost all were susceptible to chloramphenicol and cefotaxime. CONCLUSION In contrast to the studies from the low-mortality countries of the region, our study showed that the predominant pathogens of childhood ABM were SP and NM. SP meningitis was associated with increased mortality and permanent disability.
Collapse
MESH Headings
- Adolescent
- Anti-Bacterial Agents/pharmacology
- Anti-Bacterial Agents/therapeutic use
- Child
- Child, Preschool
- Drug Resistance, Bacterial
- Female
- Haemophilus influenzae/drug effects
- Haemophilus influenzae/isolation & purification
- Hospitalization
- Humans
- Infant
- Male
- Meningitis, Bacterial/microbiology
- Meningitis, Bacterial/mortality
- Meningitis, Bacterial/physiopathology
- Meningitis, Haemophilus/drug therapy
- Meningitis, Haemophilus/microbiology
- Meningitis, Haemophilus/mortality
- Meningitis, Haemophilus/physiopathology
- Meningitis, Meningococcal/drug therapy
- Meningitis, Meningococcal/microbiology
- Meningitis, Meningococcal/mortality
- Meningitis, Meningococcal/physiopathology
- Meningitis, Pneumococcal/drug therapy
- Meningitis, Pneumococcal/microbiology
- Meningitis, Pneumococcal/mortality
- Meningitis, Pneumococcal/physiopathology
- Microbial Sensitivity Tests
- Neisseria meningitidis/drug effects
- Neisseria meningitidis/isolation & purification
- Rural Population
- Streptococcus pneumoniae/drug effects
- Streptococcus pneumoniae/isolation & purification
- Survival Rate
- Yemen/epidemiology
Collapse
Affiliation(s)
- Ahmad Al Khorasani
- Sana'a University-Faculty of Medicine & Health Sciences, Department of Paediatrics, Al Seteen Road-North, Sana'a, Yemen
| | | |
Collapse
|
31
|
Füessel HS. [Meningitis: a worse prognosis with penicillin?]. MMW Fortschr Med 2006; 148:16. [PMID: 16938918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Affiliation(s)
- H S Füessel
- Geschäftsführender Schriftleiter MMW-Fortschritte der Medizin, Bezirkskrankenhaus Haar
| |
Collapse
|
32
|
Molyneux E, Riordan FAI, Walsh A. Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. ACTA ACUST UNITED AC 2006; 26:29-37. [PMID: 16494702 DOI: 10.1179/146532806x90583] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
BACKGROUND Bacterial meningitis is a serious childhood illness worldwide. Children can now be immunised against meningitis with conjugate vaccines. The outcome of bacterial meningitis in British and Malawian children before the introduction of these vaccines was compared. METHODS All children with culture-positive bacterial meningitis treated in the Royal Liverpool Children's Hospital (RLCH), UK during 1984-1991 (n=197) and in the Children's Unit, Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi during 1996-1997 (n=175) were studied. RESULTS Children at QECH presented later and were more often comatose and malnourished. Mortality was 7% in RLCH compared with 41% in QECH. Three organisms caused most cases of meningitis: N. meningitidis 56% vs 4%, H. influenzae b 27% vs 25%, and S. pneumoniae 11% vs 35% in RLCH and QECH, respectively. Mortality was lower in RLCH for each organism: N. meningitidis 10% vs 28%, H. influenzae b 6% vs 43%, S. pneumoniae 0% vs 46%. CONCLUSIONS Mortality from bacterial meningitis in Malawian children is much higher than in British children, even when infected with the same organisms. This might be owing to delay in presentation, malnutrition and HIV infection. Immunisation of Malawian children with conjugate vaccines should continue to develop since their risk of dying from meningitis is five times greater than that of British children.
Collapse
|
33
|
Harnden A, Ninis N, Thompson M, Perera R, Levin M, Mant D, Mayon-White R. Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study. BMJ 2006; 332:1295-8. [PMID: 16554335 PMCID: PMC1473085 DOI: 10.1136/bmj.38789.723611.55] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE To explore the impact on mortality and morbidity of parenteral penicillin given to children before admission to hospital with suspected meningococcal disease. DESIGN Retrospective comparison of fatal and non-fatal cases. SETTING England, Wales, and Northern Ireland; December 1997 to February 1999. PARTICIPANTS 158 children aged 0-16 years (26 died, 132 survived) in whom a general practitioner had made the diagnosis of meningococcal disease before hospital admission. RESULTS Administration of parenteral penicillin by general practitioners was associated with increased odds ratios for death (7.4, 95% confidence interval 1.5 to 37.7) and complications in survivors (5.0, 1.7 to 15.0). Children who received penicillin had more severe disease on admission (median Glasgow meningococcal septicaemia prognostic score (GMSPS) 6.5 v 4.0, P = 0.002). Severity on admission did not differ significantly with time taken to reach hospital. CONCLUSIONS Children who were given parenteral penicillin by a general practitioner had more severe disease on reaching hospital than those who were not given penicillin before admission. The association with poor outcome may be because children who are more severely ill are being given penicillin before admission.
Collapse
Affiliation(s)
- Anthony Harnden
- Department of Primary Health Care, Institute of Health Sciences, University of Oxford, Oxford OX3 7LF. Abstract
| | | | | | | | | | | | | |
Collapse
|
34
|
Affiliation(s)
- Rafael Perera
- Department of Primary Health Care, University of Oxford, Oxford OX3 7LF.
| |
Collapse
|
35
|
Skoczyńska A, Kadłubowski M, Knap J, Szulc M, Janusz-Jurczyk M, Hryniewicz W. Invasive meningococcal disease associated with a very high case fatality rate in the North-West of Poland. ACTA ACUST UNITED AC 2006; 46:230-5. [PMID: 16487304 DOI: 10.1111/j.1574-695x.2005.00027.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The aim of the study was to investigate invasive meningococcal disease in the North-West of Poland, associated with a case fatality rate of 42.9%, where among the first 11 cases, eight had fatal outcome. All fatal cases were diagnosed as fulminant meningococcal severe sepsis with Waterhouse-Friderichsen syndrome and disseminated intravascular coagulation. Serotyping and pulsed-field gel electrophoresis analysis revealed that the high case fatality rate was not associated with the dissemination of one epidemic clone. However, six cases, all with good outcomes, were caused by C:2b:(P1.2,P1.5) isolates of the same pulsed-field gel electrophoresis type belonging to ST8 complex/Cluster A4.
Collapse
Affiliation(s)
- Anna Skoczyńska
- National Reference Centre for Bacterial Meningitis, National Institute of Public Health, Warsaw, Poland.
| | | | | | | | | | | |
Collapse
|
36
|
Smith I, Caugant DA, Høiby EA, Wentzel-Larsen T, Halstensen A. High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002. Epidemiol Infect 2006; 134:1195-202. [PMID: 16650328 PMCID: PMC2870511 DOI: 10.1017/s0950268806006248] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/01/2006] [Indexed: 11/05/2022] Open
Abstract
A total of 293 meningococcal disease (McD) patients from Western Norway hospitalized during 1985-2002 were examined for risk factors related to death. The case-fatality rate (CFR) increased from 4% during 1985-1993 to 17% during 1994-2002. We analysed the phenotypic and genotypic characteristics of the meningococcal patient isolates, with the aim of identifying whether highly virulent meningococcal strains contributed to the increased CFR. The Norwegian epidemic strain B:15:P1.7,16/ST-32 complex was overall the most common phenotype/genotype (n=75) and caused most deaths (n=9; CFR 12.0%). However, fatality was significantly associated with disease caused by serogroup C meningococcal strains; C:15:P1.7,16/ST-32 and C:2a/ST-11 complex strains, which had the highest CFRs of 21.1% and 18.2% respectively. Serogroup B strains of the ST-32 complex differing by serotype and/or serosubtype from the epidemic strain had a CFR of 5.1%, while the CFR of disease caused by other strains (all phenotypes and genotypes pooled) was 2.2%. The distribution of phenotypes/clonal complexes varied significantly between 1985-1993 and 1994-2002 (P<0.001); B:15/ST-32 complex strains decreased whereas both C:15:P1.7,16/ST-32 complex strains and strains with other phenotypes/clonal complexes increased. Our results indicate that C:15:P1.7,16/ST-32 and C:2a/ST-11 complex strains were highly virulent strains and contributed to the high CFR of McD in patients from Western Norway. To reduce fatality, rapid identification of such virulent strains is necessary. In addition, early and specific measures should include public information, vaccination of populations at risk of disease and carriage eradication, when clustering of patients occurs.
Collapse
Affiliation(s)
- I Smith
- Institute of Medicine, University of Bergen, Bergen, Norway.
| | | | | | | | | |
Collapse
|
37
|
Shao Z, Li W, Ren J, Liang X, Xu L, Diao B, Li M, Lu M, Ren H, Cui Z, Zhu B, Dai Z, Zhang L, Chen X, Kan B, Xu J. Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China. Lancet 2006; 367:419-23. [PMID: 16458767 DOI: 10.1016/s0140-6736(06)68141-5] [Citation(s) in RCA: 81] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND Outbreaks of a new serogroup C meningococcal disease emerged during 2003-04 (five outbreaks with 43 cases) and in 2004-05 (five outbreaks with 29 cases), all in Anhui province, China. We describe the molecular epidemiology and features of the causative bacterial strains. METHODS We used pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST) to analyse the strains. FINDINGS Of 34 strains of Neisseria meningitidis cultured during 2003-04 from Anhui province, 31 were group C meningococci, 28 of which were associated with three of five outbreaks; one from a patient and 27 from close contacts of eight patients. Of 30 strains isolated from Anhui province during 2004-05, 17 were identified as serogroup C meningococci, ten of which were associated with four of five outbreaks. In a nationwide survey, 542 strains were isolated during 2004-05; 58 were serogroup C meningococci interspersed among 11 other provinces where no serogroup C outbreak occurred. Of the 106 serogroup C strains analysed, 89 had identical PFGE patterns, designated AH1. Of 28 strains selected for MLST analyses, 25 were sequence type 4821 (ST-4821), which did not belong to any of the previously reported sequence types that can form a new hypervirulent lineage. INTERPRETATION ST-4821 seems to be unique and caused the serogroup C meningitis outbreaks during the two seasons from 2003 to 2005 in Anhui province. The emergence of this sequence type has epidemiological importance that should be monitored for future spread in China and the rest of the world.
Collapse
Affiliation(s)
- Zhujun Shao
- National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), PO Box 5, Changping, Beijing 102206, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, Guillerm M, Alberti KP, Pinoges L, Guerin PJ, Legros D. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 2005; 366:308-13. [PMID: 16039333 DOI: 10.1016/s0140-6736(05)66792-x] [Citation(s) in RCA: 82] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND In sub-Saharan Africa in the 1990s, more than 600,000 people had epidemic meningococcal meningitis, of whom 10% died. The current recommended treatment by WHO is short-course long-acting oily chloramphenicol. Continuation of the production of this drug is uncertain, so simple alternatives need to be found. We assessed whether the efficacy of single-dose treatment of ceftriaxone was non-inferior to that of oily chloramphenicol for epidemic meningococcal meningitis. METHODS In 2003, we undertook a randomised, open-label, non-inferiority trial in nine health-care facilities in Niger. Participants with suspected disease who were older than 2 months were randomly assigned to receive either chloramphenicol or ceftriaxone. Primary outcome was treatment failure (defined as death or clinical failure) at 72 h, measured with intention-to-treat and per-protocol analyses. FINDINGS Of 510 individuals with suspected disease, 247 received ceftriaxone, 256 received chloramphenicol, and seven were lost to follow-up. The treatment failure rate at 72 h for the intention-to-treat analysis was 9% (22 patients) for both drug groups (risk difference 0.3%, 90% CI -3.8 to 4.5). Case fatality rates and clinical failure rates were equivalent in both treatment groups (14 [6%] ceftriaxone vs 12 [5%] chloramphenicol). Results were also similar for both treatment groups in individuals with confirmed meningitis caused by Neisseria meningitidis. No adverse side-effects were reported. INTERPRETATION Single-dose ceftriaxone provides an alternative treatment for epidemic meningococcal meningitis--its efficacy, ease of use, and low cost favour its use. National and international health partners should consider ceftriaxone as an alternative first-line treatment to chloramphenicol for epidemic meningococcal meningitis.
Collapse
|
39
|
Boisier P, Djibo S, Sidikou F, Mindadou H, Kairo KK, Djibo A, Goumbi K, Chanteau S. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135. Trop Med Int Health 2005; 10:435-43. [PMID: 15860090 DOI: 10.1111/j.1365-3156.2005.01394.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Since the Neisseria meningitidis serogroup W135 epidemic in Burkina Faso in 2002, the neighbouring countries dread undergoing outbreaks. Niger has strongly enhanced the microbiological surveillance, especially by adding the polymerase chain reaction (PCR) assay to the national framework of the surveillance system. During the 2003 epidemic season, 8113 clinically suspected cases of meningitis were notified and nine districts of the 42 crossed the epidemic threshold, while during the 2004 season, the number of cases was 3521 and four districts notified epidemics. In 2003 and 2004, serogroup A was identified in most N. meningitidis from cerebrospinal fluid (CSF) specimens (89.7% of 759 and 87.2% of 406, respectively). Although serogroup W135 represented only 8.3% of the meningococcal meningitis in 2003 and 7.9% in 2004, and was not involved in outbreaks, it was widespread in various areas of the country. In the regions that notified epidemics, the proportion of serogroup W135 was tiny while it exceeded 40% in several non-epidemic regions. Despite the wide distribution of W135 serogroup in Niger and the fears expressed in 2001, the threat of a large epidemic caused by N. meningitidis W135 seems to have been averted in Niger so far. There is no clear indication whether this serogroup will play a lasting role in the epidemiology of meningococcal meningitis or not. As early as in the 1990s, a significant but transient increase in the incidence of N. meningitidis serogroup X was observed. Close microbiological surveillance is crucial for monitoring the threat and for identifying at the earliest the serogroups involved in epidemics.
Collapse
Affiliation(s)
- Pascal Boisier
- CERMES, Réseau International des Instituts Pasteur, Ministère de la Santé, Niamey, Niger.
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
This epidemiological study focused on meningococcal meningitis in the Municipality of Manaus, Brazil from 1998 and 2002, considering the following aspects: incidence and case-fatality, age, sex, clinical manifestations, evolution, diagnostic criteria, and predominant meningococcal strains. The mean incidence rate for meningococcal meningitis in Manaus during the study period was 7.8 cases per 100,000 inhabitants. The disease was more common in males. Infants (< 1 year age) were the most frequently affected age group. Mean case fatality was 14.0%. In 2002, serotype B meningococcus was the most prevalent (78.2%), while serotype C accounted for 7.2% of cases of meningococcal disease.
Collapse
|
41
|
Noack R. [Meningococcus, serogroup C]. Krankenpfl J 2005; 43:16. [PMID: 15912812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Affiliation(s)
- Rainer Noack
- Institut für Infektiologie und klinische Mikrobiologie, Helios Klinikum Berlin - Klinikum Buch, Wiltbergstrasse 50, 13125 Buch
| |
Collapse
|
42
|
Domínguez A, Cardeñosa N, Pañella H, Orcau A, Companys M, Alseda M, Oviedo M, Carmona G, Minguell S, Salleras L. The case-fatality rate of meningococcal disease in Catalonia, 1990-1997. ACTA ACUST UNITED AC 2004; 36:274-9. [PMID: 15198184 DOI: 10.1080/00365540410020163] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
The objective was to analyse the case-fatality rate (CFR) of meningococcal disease (MD) in Catalonia, Spain. A retrospective study was carried out. Clinical histories of cases of MD reported for the period 1990-1997 in Catalonia were reviewed. For all cases, the variables gender, age, clinical type, y of presentation, province, phenotype and death by meningococcal disease were collected. The association between death and the other variables was studied by bivariate and unconditional logistic regression analysis. In the 2343 cases studied there were 146 deaths (6.2%) due to meningococcal disease. The CFR was higher in females (OR: 1.5, 95%CI: 1.1-2.1), in the 20 to 49 y (OR: 2.4, 95%CI: 1.2-4.9) and > or = 50 y (OR: 5.3, 95%CI: 2.8-10.1) age groups, in cases with septicaemia (OR: 2.4, 95%CI: 1.6-3.5), in the cases produced by serogroup A (OR: 4.7, 95%CI: 1.0-23.4) and in cases occurring during 1993 (OR: 2.1, 95%CI: 1.1-4.1) or in the province of Lleida (OR: 2.9, 95%CI: 1.2-7.2). In the multivariate analysis, death was associated with the 20-49 y age group (OR: 3.9, 95%CI: 1.8-8.4), the > or = 50 y age group (OR: 7.3, 95%CI: 3.6-14.7), septicaemia (OR: 3.1; 95%CI: 2.0-4.7) and residing in the province of Lleida (OR: 3.2; 95%CI: 1.2-8.5). The CFR of meningococcal disease in Catalonia was not associated with the emergent phenotype C:2b:P1.2,5 strain, which caused an outbreak in other regions of Spain.
Collapse
Affiliation(s)
- Angela Domínguez
- General Directorate of Public Health, Generalitat of Catalonia, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Abstract
BACKGROUND Short-course treatment of meningococcal disease (including meningitis) with 4-5 days of an i.v. beta-lactam is of proven efficacy. Since April 1998, all adult patients with meningococcal disease admitted to Auckland Hospital were prospectively treated with 3 days of i.v. benzylpenicillin. AIMS To assess the clinical features, laboratory findings, disease complications and outcome of patients with meningococcal disease prospectively treated with 3 days of i.v. benzylpenicillin. METHODS A retrospective chart review of all adult patients with meningococcal disease admitted to Auckland Hospital from April 1998 to December 2002 was conducted. RESULTS Ninety patients with definite (n = 72) or -probable (n = 16) meningococcal disease were admitted during the study period. Two were excluded on the basis of treatment duration. The remaining 88 patients received a mean +/- standard deviation duration of treatment of 3.1 +/- 0.5 days (excluding those who died while receiving treatment). Six patients (7%) died, four of whom while on treatment. There were no relapses. CONCLUSION Three days of i.v. benzylpenicillin for the treatment of adults with meningococcal disease is effective.
Collapse
Affiliation(s)
- S Briggs
- Infectious Diseases Unit, Auckland Hospital, Auckland, New Zealand
| | | | | | | | | |
Collapse
|
44
|
Abstract
Bacterial meningitis is uncommon but causes significant mortality and morbidity, despite optimum antibiotic therapy. A clinical trial in 301 patients showed a beneficial effect of adjunctive steroid treatment in adults with acute community-acquired pneumococcal meningitis, but data on other organisms or adverse events are sparse. This led us to do a quantitative systematic review of adjunctive steroid therapy in adults with acute bacterial meningitis. Five trials involving 623 patients were included (pneumococcal meningitis=234, meningococcal meningitis=232, others=127, unknown=30). Overall, treatment with steroids was associated with a significant reduction in mortality (relative risk 0.6, 95% CI 0.4-0.8, p=0.002) and in neurological sequelae (0.6, 0.4-1, p=0.05), and with a reduction of case-fatality in pneumococcal meningitis of 21% (0.5, 0.3-0.8, p=0.001). In meningococcal meningitis, mortality (0.9, 0.3-2.1) and neurological sequelae (0.5, 0.1-1.7) were both reduced, but not significantly. Adverse events, recorded in 391 cases, were equally divided between the treatment and placebo groups (1, 0.5-2), with gastrointestinal bleeding in 1% of steroid-treated and 4% of other patients. Since treatment with steroids reduces both mortality and neurological sequelae in adults with bacterial meningitis, without detectable adverse effects, routine steroid therapy with the first dose of antibiotics is justified in most adult patients in whom acute community-acquired bacterial meningitis is suspected.
Collapse
MESH Headings
- Acute Disease
- Adult
- Anti-Infective Agents/therapeutic use
- Chemotherapy, Adjuvant
- Community-Acquired Infections/complications
- Community-Acquired Infections/drug therapy
- Community-Acquired Infections/mortality
- Drug Therapy, Combination
- Female
- Humans
- Male
- Meningitis, Bacterial/complications
- Meningitis, Bacterial/drug therapy
- Meningitis, Bacterial/mortality
- Meningitis, Meningococcal/complications
- Meningitis, Meningococcal/drug therapy
- Meningitis, Meningococcal/mortality
- Meningitis, Pneumococcal/complications
- Meningitis, Pneumococcal/drug therapy
- Meningitis, Pneumococcal/mortality
- Meta-Analysis as Topic
- Randomized Controlled Trials as Topic
- Steroids/adverse effects
- Steroids/therapeutic use
- Treatment Outcome
Collapse
Affiliation(s)
- Diederik van de Beek
- Department of Neurology, Academic Medical Centre, University of Amsterdam, Netherlands.
| | | | | | | |
Collapse
|
45
|
[Bacterial meningitis]. Krankenpfl J 2004; 42:5-7. [PMID: 15116764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
|
46
|
Mengistu G, Mitiku K, Teferi W. Analysis and reporting of meningococcal meningitis epidemic in north Gondar 2001-2002. Ethiop Med J 2003; 41:319-31. [PMID: 15296414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
Severe epidemic meningococcal meningitis occurs in countries of the meningitis belt of Sub-Saharan Africa, including Ethiopia. Many epidemics occurred in this country in the past decade, the recent being in 2000 in Addis Ababa unusually during the wet and rainy season. The study was a cross-sectional design. Data were collected with prepared questionnaires and the line listing. CSF (Cerebro Spinal Fluid) culture and antibiotic sensitivities were done for a limited number of patients. The objective of the study was to assess the progress and management outcome of the epidemic. During the out breaks of epidemic meningitis in north Gondar zone of the Amhara regional state in 2001 and 2002 children and young adults were most affected. There were 384 cases and 26 deaths in 2001 and 1235 cases and 128 deaths, in 2002, making a total of 1619 cases and 154 deaths with a case fatality rate of 9.5%. The etiologic agent was sero-group A. The most affected age group was 15-30 years. About 80% of the cases were in the age 30 years and below. Surveillance, epidemic preparedness, interventions and response were found to be inadequate. Selective vaccination was not effective in handling the epidemic. Efficient surveillance, local processing and use of data, regional laboratory support, multisectoral approach and mass vaccination were recommended to appropriately and timely handle such epidemics.
Collapse
Affiliation(s)
- Getahun Mengistu
- Department of Internal Medicine, Gondar College of Medical Sciences PO Box 196, Gondar, Ethiopia
| | | | | |
Collapse
|
47
|
Wilder-Smith A, Goh KT, Barkham T, Paton NI. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis 2003; 36:679-83. [PMID: 12627350 DOI: 10.1086/367858] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2002] [Accepted: 10/08/2002] [Indexed: 11/03/2022] Open
Abstract
An outbreak of disease due to Neisseria meningitidis serogroup W135 (W135) occurred in 2000 and 2001 among pilgrims returning from the annual Islamic pilgrimage to Saudi Arabia (the Hajj) and in their contacts. For the Hajj in 2000, the attack rate of W135 disease was 25 cases per 100,000 pilgrims. After the introduction of quadrivalent meningococcal vaccine for the Hajj in 2001, no pilgrim developed W135 disease. The estimated attack rates for household contacts of returning pilgrims were 18 cases and 28 cases per 100,000 contacts for the years 2000 and 2001, respectively. On the basis of rates of transmission of W135 carriage and national epidemiological data, the risk that an unvaccinated household contact who had acquired W135 carriage would develop invasive meningococcal disease was estimated to be 1 case per 70 acquisitions. Public health policies to protect household contacts of Hajj pilgrims need to be implemented.
Collapse
Affiliation(s)
- Annelies Wilder-Smith
- Travellers' Health and Vaccination Centre, Dept. of Infectious Diseases, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.
| | | | | | | |
Collapse
|
48
|
Abstract
Study of the epidemiologic trends in meningococcal disease is important in understanding infection dynamics and developing timely and appropriate public health interventions. We studied surveillance data from the New York City Department of Health and Mental Hygiene, which showed that during 1989-2000 a decrease occurred in both the proportion of patients with serogroup B infection (from 28% to 13% of reported cases; p<0.01) and the rate of serogroup B infection (from 0.25/100,000 to 0.08/100,000; p<0.01). We also noted an increased proportion (from 3% to 39%; p<0.01) and rate of serogroup Y infection (from 0.02/100,000 to 0.23/100,000; p<0.01). Median patient age increased (from 15 to 30 years; p<0.01). The case-fatality rate for the period was 17%. As more effective meningococcal vaccines become available, recommendations for their use in nonepidemic settings should consider current epidemiologic trends, particularly changes in age and serogroup distribution of meningococcal infections.
Collapse
Affiliation(s)
- Alexandre Sampaio Moura
- New York City Department of Health and Mental Hygiene, New York, New York, USA
- Columbia University, New York, New York, USA
| | - Ariel Pablos-Méndez
- Columbia University, New York, New York, USA
- Rockefeller Foundation, New York, New York, USA
| | - Marcelle Layton
- New York City Department of Health and Mental Hygiene, New York, New York, USA
| | - Don Weiss
- New York City Department of Health and Mental Hygiene, New York, New York, USA
| |
Collapse
|
49
|
Mastrantonio P, Stefanelli P, Fazio C, Sofia T, Neri A, La Rosa G, Marianelli C, Muscillo M, Caporali MG, Salmaso S. Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy. Clin Infect Dis 2003; 36:422-8. [PMID: 12567299 DOI: 10.1086/346154] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2002] [Accepted: 10/28/2002] [Indexed: 11/03/2022] Open
Abstract
The availability of new polysaccharide-protein conjugate vaccines against Neisseria meningitidis serogroup C prompted European National Health authorities to carefully monitor isolate characteristics. In Italy, during 1999-2001, the average incidence was 0.4 cases per 100,000 inhabitants. Serogroup B was predominant and accounted for 75% of the isolates, followed by serogroup C with 24%. Serogroup C was isolated almost twice as frequently in cases of septicemia than in cases of meningitis, and the most common phenotypes were C:2a:P1.5 and C:2b:P1.5. Among serogroup B meningococci, the trend of predominant phenotypes has changed from year to year, with a recent increase in the frequency of B:15:P1.4. Only a few meningococci had decreased susceptibility to penicillin, and, in the penA gene, all of these strains had exogenous DNA blocks deriving from the DNA of commensal Neisseria flavescens, Neisseria cinerea, and Neisseria perflava/sicca. Fluorescent amplified fragment-length polymorphism analysis revealed the nonclonal nature of the strains with decreased susceptibility to penicillin.
Collapse
Affiliation(s)
- Paola Mastrantonio
- Laboratory of Bacteriology and Medical Mycology, Istituto Superiore di Sanità, Rome, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Jensen ES, Schønheyder HC, Lind I, Berthelsen L, Nørgård B, Sørensen HT. Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county. J Med Microbiol 2003; 52:173-179. [PMID: 12543925 DOI: 10.1099/jmm.0.04817-0] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The incidence rate (IR) and case-fatality rate (CFR) of meningococcal disease increased during the late 1980s and early 1990s in North Jutland County, Denmark. We examined the hypothesis that phenotypic markers of Neisseria meningitidis are predictors of septicaemia with or without meningitis, rapid disease progress and fatal outcome of meningococcal disease and we studied whether changes in IR and CFR over time might be related to emergence or spread of certain phenotypes. This follow-up study was based on a complete registration of 413 cases of meningococcal disease in North Jutland County during 1980-99. Phenotypic markers included serogroup, serotype and serosubtype. A complete phenotype was available for 315 cases (76 %); 100 (32 %) strains were phenotype B : 15 : P1.7,16 and 31 (10 %) were C : 2a : P1.2,5. Septicaemia without meningitis was less common in cases with B : 15 : P1.7,16 and C : 2a : P1.2,5 strains. No association was found between phenotype and rapid disease progress. The overall CFR was 12 %. An increased CFR was associated with phenotypes B : 15 : P1.7,16 [odds ratio (OR) 2.8, 95 % confidence interval (CI) 1.2-18.5] and C : 2a : P1.2,5 (OR 5.2, 95 % CI 1.6-16.4) when compared with other phenotypes. The prevalence of B : 15 : P1.7,16 strains increased gradually during the study period and the CFR increased from 8 % during 1980-89 to 19 % during 1990-99, although the CFR for other phenotypes also increased. The CFR for C : 2a : P1.2,5 remained high ( approximately 20 %), but the contribution of this phenotype to the overall CFR decreased during the study period. In conclusion, phenotypes B : 15 : P1.7,16 and C : 2a : P1.2,5 were predictors of an increased CFR. The high prevalence of phenotype B : 15 : P1.7,16 contributed to increased overall IR and CFR during 1990-99.
Collapse
Affiliation(s)
- Elise Snitker Jensen
- Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Henrik C Schønheyder
- Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Inga Lind
- Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Lene Berthelsen
- Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Bente Nørgård
- Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Henrik Toft Sørensen
- Department of Clinical Epidemiology, Aalborg and Aarhus University Hospital, Stengade 10, 2nd floor, DK-9000 Aalborg, Denmark 2Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Denmark 3The Neisseria Unit, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| |
Collapse
|